HEADER TRANSFERASE/TRANSFERASE INHIBITOR 29-JUL-15 5CXH TITLE SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT ORALLY BIOAVAILABLE TITLE 2 THIAZOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN RESIDUES 356-635; COMPND 5 SYNONYM: SPLEEN TYROSINE KINASE,P72-SYK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.C.LEE REVDAT 4 06-MAR-24 5CXH 1 REMARK REVDAT 3 16-DEC-15 5CXH 1 REMARK REVDAT 2 28-OCT-15 5CXH 1 JRNL REVDAT 1 23-SEP-15 5CXH 0 JRNL AUTH G.THOMA,S.VEENSTRA,R.STRANG,J.BLANZ,E.VANGREVELINGHE, JRNL AUTH 2 J.BERGHAUSEN,C.C.LEE,H.G.ZERWES JRNL TITL ORALLY BIOAVAILABLE SYK INHIBITORS WITH ACTIVITY IN A RAT JRNL TITL 2 PK/PD MODEL. JRNL REF BIOORG.MED.CHEM.LETT. V. 25 4642 2015 JRNL REFN ESSN 1464-3405 JRNL PMID 26320624 JRNL DOI 10.1016/J.BMCL.2015.08.037 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 24439 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1242 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.61 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2698 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2072 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2558 REMARK 3 BIN R VALUE (WORKING SET) : 0.2058 REMARK 3 BIN FREE R VALUE : 0.2344 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.19 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 140 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2243 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 214 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.97450 REMARK 3 B22 (A**2) : -0.70070 REMARK 3 B33 (A**2) : -1.27370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.206 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.148 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.129 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.138 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.125 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2328 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3148 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 813 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 59 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 331 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2328 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 278 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2867 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.99 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.16 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.17 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|363 - A|639 } REMARK 3 ORIGIN FOR THE GROUP (A): 3.9583 10.6812 19.4215 REMARK 3 T TENSOR REMARK 3 T11: -0.0406 T22: -0.0579 REMARK 3 T33: -0.0664 T12: -0.0108 REMARK 3 T13: 0.0050 T23: 0.0062 REMARK 3 L TENSOR REMARK 3 L11: 1.1159 L22: 1.2894 REMARK 3 L33: 0.6172 L12: -0.5179 REMARK 3 L13: -0.4591 L23: 0.0722 REMARK 3 S TENSOR REMARK 3 S11: -0.0505 S12: -0.0739 S13: 0.0238 REMARK 3 S21: 0.0119 S22: 0.0591 S23: -0.0177 REMARK 3 S31: 0.0420 S32: 0.0559 S33: -0.0086 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5CXH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000212314. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24752 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.52100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 0.2M POTASSIUM FLUORIDE, REMARK 280 NO BUFFER PH 7.3, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.03800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.67150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.03800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.67150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 353 REMARK 465 ALA A 354 REMARK 465 LEU A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 ILE A 358 REMARK 465 ARG A 359 REMARK 465 PRO A 360 REMARK 465 LYS A 361 REMARK 465 GLU A 362 REMARK 465 HIS A 640 REMARK 465 HIS A 641 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 393 CE NZ REMARK 470 LYS A 533 CG CD CE NZ REMARK 470 LYS A 571 CD CE NZ REMARK 470 HIS A 637 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 394 -56.03 -139.04 REMARK 500 ALA A 441 -119.76 -128.91 REMARK 500 ASP A 494 39.27 -150.82 REMARK 500 ASP A 512 83.68 56.74 REMARK 500 LYS A 533 96.35 -68.96 REMARK 500 TRP A 609 33.14 -89.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 55M A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4RX7 RELATED DB: PDB REMARK 900 RELATED ID: 4RX8 RELATED DB: PDB REMARK 900 RELATED ID: 4RX9 RELATED DB: PDB DBREF 5CXH A 356 635 UNP P43405 KSYK_HUMAN 356 635 SEQADV 5CXH MET A 353 UNP P43405 INITIATING METHIONINE SEQADV 5CXH ALA A 354 UNP P43405 EXPRESSION TAG SEQADV 5CXH LEU A 355 UNP P43405 EXPRESSION TAG SEQADV 5CXH THR A 467 UNP P43405 LYS 467 ENGINEERED MUTATION SEQADV 5CXH HIS A 636 UNP P43405 EXPRESSION TAG SEQADV 5CXH HIS A 637 UNP P43405 EXPRESSION TAG SEQADV 5CXH HIS A 638 UNP P43405 EXPRESSION TAG SEQADV 5CXH HIS A 639 UNP P43405 EXPRESSION TAG SEQADV 5CXH HIS A 640 UNP P43405 EXPRESSION TAG SEQADV 5CXH HIS A 641 UNP P43405 EXPRESSION TAG SEQRES 1 A 289 MET ALA LEU GLU GLU ILE ARG PRO LYS GLU VAL TYR LEU SEQRES 2 A 289 ASP ARG LYS LEU LEU THR LEU GLU ASP LYS GLU LEU GLY SEQRES 3 A 289 SER GLY ASN PHE GLY THR VAL LYS LYS GLY TYR TYR GLN SEQRES 4 A 289 MET LYS LYS VAL VAL LYS THR VAL ALA VAL LYS ILE LEU SEQRES 5 A 289 LYS ASN GLU ALA ASN ASP PRO ALA LEU LYS ASP GLU LEU SEQRES 6 A 289 LEU ALA GLU ALA ASN VAL MET GLN GLN LEU ASP ASN PRO SEQRES 7 A 289 TYR ILE VAL ARG MET ILE GLY ILE CYS GLU ALA GLU SER SEQRES 8 A 289 TRP MET LEU VAL MET GLU MET ALA GLU LEU GLY PRO LEU SEQRES 9 A 289 ASN LYS TYR LEU GLN GLN ASN ARG HIS VAL THR ASP LYS SEQRES 10 A 289 ASN ILE ILE GLU LEU VAL HIS GLN VAL SER MET GLY MET SEQRES 11 A 289 LYS TYR LEU GLU GLU SER ASN PHE VAL HIS ARG ASP LEU SEQRES 12 A 289 ALA ALA ARG ASN VAL LEU LEU VAL THR GLN HIS TYR ALA SEQRES 13 A 289 LYS ILE SER ASP PHE GLY LEU SER LYS ALA LEU ARG ALA SEQRES 14 A 289 ASP GLU ASN TYR TYR LYS ALA GLN THR HIS GLY LYS TRP SEQRES 15 A 289 PRO VAL LYS TRP TYR ALA PRO GLU CYS ILE ASN TYR TYR SEQRES 16 A 289 LYS PHE SER SER LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 289 LEU MET TRP GLU ALA PHE SER TYR GLY GLN LYS PRO TYR SEQRES 18 A 289 ARG GLY MET LYS GLY SER GLU VAL THR ALA MET LEU GLU SEQRES 19 A 289 LYS GLY GLU ARG MET GLY CYS PRO ALA GLY CYS PRO ARG SEQRES 20 A 289 GLU MET TYR ASP LEU MET ASN LEU CYS TRP THR TYR ASP SEQRES 21 A 289 VAL GLU ASN ARG PRO GLY PHE ALA ALA VAL GLU LEU ARG SEQRES 22 A 289 LEU ARG ASN TYR TYR TYR ASP VAL VAL ASN HIS HIS HIS SEQRES 23 A 289 HIS HIS HIS HET 55M A 701 28 HETNAM 55M (4R)-4-[(1R)-1-{[6-(3,4-DIMETHOXYPHENYL)[1, HETNAM 2 55M 3]THIAZOLO[5,4-C]PYRIDIN-4-YL]OXY}ETHYL]PYRROLIDIN-2- HETNAM 3 55M ONE FORMUL 2 55M C20 H21 N3 O4 S FORMUL 3 HOH *214(H2 O) HELIX 1 AA1 ASP A 366 LYS A 368 5 3 HELIX 2 AA2 ASP A 410 GLN A 426 1 17 HELIX 3 AA3 LEU A 456 ASN A 463 1 8 HELIX 4 AA4 THR A 467 SER A 488 1 22 HELIX 5 AA5 ALA A 496 ARG A 498 5 3 HELIX 6 AA6 PRO A 535 TYR A 539 5 5 HELIX 7 AA7 ALA A 540 TYR A 547 1 8 HELIX 8 AA8 SER A 551 SER A 567 1 17 HELIX 9 AA9 LYS A 577 LYS A 587 1 11 HELIX 10 AB1 PRO A 598 TRP A 609 1 12 HELIX 11 AB2 GLY A 618 HIS A 639 1 22 SHEET 1 AA1 5 LEU A 370 SER A 379 0 SHEET 2 AA1 5 THR A 384 GLN A 391 -1 O VAL A 385 N LEU A 377 SHEET 3 AA1 5 VAL A 396 ILE A 403 -1 O VAL A 401 N LYS A 386 SHEET 4 AA1 5 TRP A 444 GLU A 449 -1 O MET A 448 N ALA A 400 SHEET 5 AA1 5 MET A 435 GLU A 440 -1 N ILE A 436 O VAL A 447 SHEET 1 AA2 3 GLY A 454 PRO A 455 0 SHEET 2 AA2 3 VAL A 500 THR A 504 -1 O LEU A 502 N GLY A 454 SHEET 3 AA2 3 TYR A 507 ILE A 510 -1 O TYR A 507 N VAL A 503 SHEET 1 AA3 2 PHE A 490 VAL A 491 0 SHEET 2 AA3 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 AA4 2 TYR A 525 LYS A 527 0 SHEET 2 AA4 2 LYS A 548 SER A 550 -1 O PHE A 549 N TYR A 526 SITE 1 AC1 15 LEU A 377 GLY A 378 GLY A 380 ALA A 400 SITE 2 AC1 15 LYS A 402 GLU A 449 ALA A 451 GLU A 452 SITE 3 AC1 15 GLY A 454 PRO A 455 LYS A 458 LEU A 501 SITE 4 AC1 15 SER A 511 ASP A 512 HOH A 936 CRYST1 40.000 85.343 90.076 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025000 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011717 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011102 0.00000